John Golubieski - 27 Jan 2022 Form 4 Insider Report for BIODELIVERY SCIENCES INTERNATIONAL INC

Role
Chief Financial Officer and Treasurer
Signature
John Golubieski
Issuer symbol
N/A
Transactions as of
27 Jan 2022
Net transactions value
+$1,367,131
Form type
4
Filing time
31 Jan 2022, 16:59:57 UTC
Previous filing
05 Nov 2021
Next filing
22 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSI Stock Options (right to buy) Award $1,367,131 +373,533 $3.66 373,533 27 Jan 2022 Common Stock 373,533 $3.66 Direct F1, F2
transaction BDSI Restricted Stock Units Award $0 +66,940 $0.000000 66,940 27 Jan 2022 Common Stock 66,940 $0.000000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022.
F2 The stock options were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the "Plan"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
F3 The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
F4 Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.

Remarks:

Chief Financial Officer and Treasurer